Priority Date: 11.01.08 (US 20080020573P)

Polypeptide vaccine and vaccination strategy against mycobacterium

  • Application ID: EP14176196
  • Status: █ EXAMINATION IN PROGRESS

Attorneys

Employment test 11 - 50 employees
Missing person image thumb Missing person image thumb Missing person image thumb
Company dna hoiberg a slash s
operating since 1995
910.43
Høiberg A/S
Headquarter in Copenhagen and 1 office
active in Legal Services and IP Consulting
Employment test 11 - 50 employees
Missing person image thumb Missing person image thumb Missing person image thumb
Company dna abg patentes sl
operating since 2003
980.76
ABG Patentes SL
Headquarter in Madrid and 1 office
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) Høiberg A/S and ABG Patentes SL are specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 187 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 11.01.2008 - Priority Date (US 20080020573P)
  • 31.12.2014 - Publication A1 (EP2818178)

IPC Classification